Yunfeng Xia1, Xiaogao Jin1, Jingyin Yan1, Mark L Entman1, Yanlin Wang2. 1. From the Division of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX (Y.X., X.J., J.Y., Y.W.); Division of Nephrology, Department of Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Y.X.); Division of Cardiovascular Sciences, Department of Medicine and the DeBakey Heart Center, Baylor College of Medicine and The Methodist Hospital, Houston, TX (M.L.E.); and Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX (Y.W.). 2. From the Division of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX (Y.X., X.J., J.Y., Y.W.); Division of Nephrology, Department of Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Y.X.); Division of Cardiovascular Sciences, Department of Medicine and the DeBakey Heart Center, Baylor College of Medicine and The Methodist Hospital, Houston, TX (M.L.E.); and Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX (Y.W.). yanlinw@bcm.edu.
Abstract
OBJECTIVE: Recent studies have shown that angiotensin II (Ang II) plays a critical role in the pathogenesis and progression of hypertensive kidney disease. However, the signaling mechanisms are poorly understood. In this study, we investigated the role of CXCR6 in Ang II-induced renal injury and fibrosis. APPROACH AND RESULTS: Wild-type and CXCR6-green fluorescent protein (GFP) knockin mice were treated with Ang II via subcutaneous osmotic minipumps at 1500 ng/kg per minute after unilateral nephrectomy for ≤ 4 weeks. Wild-type and CXCR6-GFP knockin mice had virtually identical blood pressure at baseline. Ang II treatment led to an increase in blood pressure that was similar between wild-type and CXCR6-GFP knockin mice. CXCR6-GFP knockin mice were protected from Ang II-induced renal dysfunction, proteinuria, and fibrosis. CXCR6-GFP knockin mice accumulated fewer bone marrow-derived fibroblasts and myofibroblasts and produced less extracellular matrix protein in the kidneys after Ang II treatment. Furthermore, CXCR6-GFP knockin mice exhibited fewer F4/80(+) macrophages and CD3(+) T cells and expressed less proinflammatory cytokines in the kidneys after Ang II treatment. Finally, wild-type mice engrafted with CXCR6(-/-) bone marrow cells displayed fewer bone marrow-derived fibroblasts, macrophages, and T cells in the kidney after Ang II treatment when compared with wild-type mice engrafted with CXCR6(+/+) bone marrow cells. CONCLUSIONS: Our results indicate that CXCR6 plays a pivotal role in the development of Ang II-induced renal injury and fibrosis through regulation of macrophage and T-cell infiltration and bone marrow-derived fibroblast accumulation.
OBJECTIVE: Recent studies have shown that angiotensin II (Ang II) plays a critical role in the pathogenesis and progression of hypertensive kidney disease. However, the signaling mechanisms are poorly understood. In this study, we investigated the role of CXCR6 in Ang II-induced renal injury and fibrosis. APPROACH AND RESULTS: Wild-type and CXCR6-green fluorescent protein (GFP) knockin mice were treated with Ang II via subcutaneous osmotic minipumps at 1500 ng/kg per minute after unilateral nephrectomy for ≤ 4 weeks. Wild-type and CXCR6-GFP knockin mice had virtually identical blood pressure at baseline. Ang II treatment led to an increase in blood pressure that was similar between wild-type and CXCR6-GFP knockin mice. CXCR6-GFP knockin mice were protected from Ang II-induced renal dysfunction, proteinuria, and fibrosis. CXCR6-GFP knockin mice accumulated fewer bone marrow-derived fibroblasts and myofibroblasts and produced less extracellular matrix protein in the kidneys after Ang II treatment. Furthermore, CXCR6-GFP knockin mice exhibited fewer F4/80(+) macrophages and CD3(+) T cells and expressed less proinflammatory cytokines in the kidneys after Ang II treatment. Finally, wild-type mice engrafted with CXCR6(-/-) bone marrow cells displayed fewer bone marrow-derived fibroblasts, macrophages, and T cells in the kidney after Ang II treatment when compared with wild-type mice engrafted with CXCR6(+/+) bone marrow cells. CONCLUSIONS: Our results indicate that CXCR6 plays a pivotal role in the development of Ang II-induced renal injury and fibrosis through regulation of macrophage and T-cell infiltration and bone marrow-derived fibroblast accumulation.
Authors: Martine Broekema; Martin C Harmsen; Marja J A van Luyn; Jasper A Koerts; Arjen H Petersen; Theo G van Kooten; Harry van Goor; Gerjan Navis; Eliane R Popa Journal: J Am Soc Nephrol Date: 2006-11-29 Impact factor: 10.121
Authors: Elena Galkina; Brian L Harry; Andreas Ludwig; Elisa A Liehn; John M Sanders; Anthony Bruce; Christian Weber; Klaus Ley Journal: Circulation Date: 2007-10-01 Impact factor: 29.690
Authors: Gang Chen; Song-Chang Lin; Jiyuan Chen; Liqun He; Feixia Dong; Jing Xu; Shuhua Han; Jie Du; Mark L Entman; Yanlin Wang Journal: J Am Soc Nephrol Date: 2011-08-04 Impact factor: 10.121
Authors: Sandra B Haudek; Jizhong Cheng; Jie Du; Yanlin Wang; Jesus Hermosillo-Rodriguez; JoAnn Trial; George E Taffet; Mark L Entman Journal: J Mol Cell Cardiol Date: 2010-05-19 Impact factor: 5.000
Authors: Steven D Crowley; Campbell W Frey; Samantha K Gould; Robert Griffiths; Phillip Ruiz; James L Burchette; David N Howell; Natalia Makhanova; Ming Yan; Hyung-Suk Kim; Pierre-Louis Tharaux; Thomas M Coffman Journal: Am J Physiol Renal Physiol Date: 2008-05-21
Authors: Marianne Niedermeier; Barbara Reich; Manuel Rodriguez Gomez; Andrea Denzel; Kathrin Schmidbauer; Nicole Göbel; Yvonne Talke; Frank Schweda; Matthias Mack Journal: Proc Natl Acad Sci U S A Date: 2009-10-06 Impact factor: 11.205
Authors: Nicolas Picard; Oliver Baum; Alexander Vogetseder; Brigitte Kaissling; Michel Le Hir Journal: Histochem Cell Biol Date: 2008-05-01 Impact factor: 4.304
Authors: Tomasz J Guzik; Nyssa E Hoch; Kathryn A Brown; Louise A McCann; Ayaz Rahman; Sergey Dikalov; Jorg Goronzy; Cornelia Weyand; David G Harrison Journal: J Exp Med Date: 2007-09-17 Impact factor: 14.307
Authors: Jing Wu; Kim Ramil C Montaniel; Mohamed A Saleh; Liang Xiao; Wei Chen; Gary K Owens; Jay D Humphrey; Mark W Majesky; David T Paik; Antonis K Hatzopoulos; Meena S Madhur; David G Harrison Journal: Hypertension Date: 2015-12-22 Impact factor: 10.190